Eos SENOLYTIX, Inc.
PrivateLast Round
Series A
Feb 23, 2025
Est. Valuation
$150M
Company Overview
Eos SENOLYTIX, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Private Placement round in March 2024.
Eos SENOLYTIX, Inc. is a biotechnology company that develops gerotherapeutic peptide medicines targeting mitochondrial dysfunction and senescent cells to improve healthspan and treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eos SENOLYTIX, Inc. Comparables
Compare Eos SENOLYTIX, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deciduous Therapeutics | 84% | |
| Cleara Biotech | 81% | |
| Rubedo Life Sciences | 81% |
For institutional investors. Book with your work email.
Eos SENOLYTIX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 23, 2025 | ||||
| Private Placement | Mar 26, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eos SENOLYTIX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rosalind Advisors | Private Placement |
| Rapha Capital Management | Series A |
| Heights Capital Management | Private Placement |
| HealthpointCapital | Private Placement |
| Empery Asset Management | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 107% MoM, reaching 1.5K.
- Mar 1, 2026
Monthly visitors increased 85% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 22, 2026
Eos SENOLYTIX, Inc. presents preclinical survival, healthspan, and mechanism-of-action data for PTC-2105 in an Industry Keynote Address at the 17th World Congress on Targeting Mitochondria in Germany on Oct 22nd '26.
- launchesOct 22, 2026
Eos SENOLYTIX, Inc. launches the “Team Speedy” webpage at eossenolytix.com/team-speedy in Germany on Oct 22nd '26, inviting the public to watch its longest-lived mouse, predict how far he goes, and sign up for milestone alerts.
For institutional investors. Book with your work email.
Eos SENOLYTIX, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eos SENOLYTIX, Inc.'s valuation, stock price, and market status.
Is Eos SENOLYTIX, Inc. a public or private company?
Eos SENOLYTIX, Inc. is a private company.
What is the current stock price of Eos SENOLYTIX, Inc.?
Eos SENOLYTIX, Inc. is a private company, so its shares have no public market price. Caplight tracks Eos SENOLYTIX, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eos SENOLYTIX, Inc. worth (valuation)?
Eos SENOLYTIX, Inc.'s valuation is estimated at $150.0M based on funding round data.
Can I buy Eos SENOLYTIX, Inc. stock?
Eos SENOLYTIX, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eos SENOLYTIX, Inc.'s last funding round?
Eos SENOLYTIX, Inc.'s most recent funding round was Series A on February 23, 2025.
Who are the main investors in Eos SENOLYTIX, Inc.?
Key investors in Eos SENOLYTIX, Inc. include Rosalind Advisors, Rapha Capital Management, HealthpointCapital.
Will Eos SENOLYTIX, Inc. IPO soon?
No public IPO plans have been announced for Eos SENOLYTIX, Inc..
How can I track Eos SENOLYTIX, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Eos SENOLYTIX, Inc.'s shares on secondary markets.